Vaccines Market Reports

Kalorama Information studies on the pharmaceutical vaccines industry cover the global market opportunity in full, with data on major competitors, market direction, and the pediatric and adult segments. Kalorama reports examine the global vaccines market by region, including the US, South America, EU, Japan, India, and China, as well as by type, including hepatitis, pneumococcal, cervical cancer, and influenza, among others. Market share of major vaccine companies is reported as well.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Jan 23, 2017 | Price: $4,500.00
The Market for Urgent Care Centers (Clinic Locations and Growth, Revenues by Procedure, Diagnostic and Vaccine Sales to Clinics, Operator Profiles) This Kalorama Information report, The Market for Urgent Care Centers, is a detailed look at the current state of these healthcare outlets, including...
Published: Sep 2, 2016 | Price: $4,200.00
 In this research report, Kalorama Information provides data including sales forecasts and store counts for health clinics located in drugstores and other retail locations in the U.s., as well as forecasts for IVD and pharmaceutical products that are sold to them.  Major clinic providers are...
Published: Mar 25, 2016 | Price: $4,200.00
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others) Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types...
Published: Nov 12, 2015 | Price: $3,000.00
This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach...
Published: Mar 3, 2015 | Price: $500.00
Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends Retail health clinics are a fast-growing and unique segment of the U.S. health care system. A concept less...
Published: Aug 29, 2014 | Price: $3,995.00
Biopharmaceutical and Vaccine Production Markets Biopharmaceutical and Vaccine Production Markets analyzes the entire manufacturing market for biologic drugs, including both outsourcing and costs by major maufacturers spending internally on biopharmaceutical and vaccine production.As part of its...
Published: Apr 21, 2014 | Price: $995.00
Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The...
Published: Dec 4, 2012 | Price: $500.00
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report,...
Published: Oct 18, 2012 | Price: $3,995.00
Vaccines are an important part of the business model of top pharmaceutical companies. The success of several recent vaccine product introductions has been of great interest to pharma R&D efforts. The high growth rates and successful launch of several products recently have kept interest in...
Published: Sep 19, 2012 | Price: $1,500.00
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently...
Published: Jun 5, 2012 | Price: $3,995.00
Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be...
Published: Feb 1, 2012 | Price: $2,500.00
Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? ...
Published: Jul 1, 2011 | Price: $150.00
The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product...
Published: Jul 1, 2011 | Price: $150.00
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies...
Published: May 1, 2011 | Price: $150.00
Convenience clinics, also known as retail health clinics, are a quickly growing segment of the U.S. health care marketplace, although their expansion has slowed somewhat from the very high rates of their early years. This report looks at retail clinics’ impact and growth over the next five years. ...
Published: Mar 25, 2011 | Price: $150.00
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the...
Published: Nov 1, 2010 | Price: $995.00
The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase...
Published: Sep 1, 2010 | Price: $1,500.00
Kalorama has been researching and examining the development of cancer vaccines for seven years. In April 2010, the cancer vaccine market experienced one of the biggest achievements in the therapeutic vaccine treatment of cancer—the approval of the prostate cancer vaccine PROVENGE (TM). This,...
Published: Aug 1, 2010 | Price: $3,995.00
Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for...
Published: May 1, 2010 | Price: $500.00
The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an...
Published: Feb 1, 2010 | Price: $1,500.00
The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines...
Published: Oct 1, 2009 | Price: $995.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe...
Published: Oct 1, 2009 | Price: $995.00
At their most basic level, wellness programs represent an attempt to encourage good health and thereby decrease utilization of health care products and services. They have evolved out of necessity from the current U.S. health care system, in response to a variety of factors including continually...
Published: Sep 1, 2009 | Price: $2,995.00
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides...
Published: Jun 1, 2009 | Price: $3,995.00
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. This report, Vaccines 2009: Key Players, and Critical Trends in a...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.